Vancomycin Enema denied due to quantity / dose limits by Humana?

Humana's specific coverage criteria for vancomycin enema are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Vancomycin Enema for Quantity Limits

Humana applies quantity limits to many compounded preparations to prevent overutilization and ensure that the amount dispensed matches approved clinical protocols. A quantity-limit denial means the prescription as written exceeds the quantity Humana considers appropriate for a defined supply period. This is common with compounded enemas, where the prescribed course of therapy may span a longer duration or higher frequency than a default coverage limit contemplates.

## Why This Denial Is Appealable

Quantity limits are administrative defaults, not individualized clinical determinations. When a prescriber documents that the patient's clinical condition requires a quantity or treatment duration beyond the default limit — for example, due to disease severity, a prolonged treatment course, or a recurrent condition — that medical necessity documentation is the basis for a successful quantity-limit exception. Humana's own policies typically include an exception process for clinically justified quantities.

## Federal Appeal Framework

• Internal appeal: Submit within the timeframe noted on the denial letter. Humana must decide pre-service appeals within 30 days and post-service within 60 days.
• Expedited review: Request simultaneously if clinical urgency exists; Humana must respond within 72 hours.
• External review (ACA §2719 / ERISA §503): After a final adverse internal decision, request IRO review within approximately 4 months. The IRO's decision is binding.

## Documentation to Gather

• Prescriber letter specifying clinical rationale for quantity: The prescriber should explain why the prescribed amount and frequency are necessary for this patient's specific disease course, not just the default condition.
• Diagnosis and severity documentation: Chart notes quantifying disease severity and extent of colorectal involvement.
• Treatment course plan: A clear statement from the prescriber of the expected total treatment duration and why a shorter or smaller quantity is clinically inadequate.
• Prior-treatment history: Evidence of prior attempts with alternatives that were insufficient, supporting the need for an extended or higher-quantity course.

## Criteria-Mapping Structure

Retrieve Humana's published quantity-limit policy for compounded vancomycin enema (or compounded drugs generally). List each condition under which a quantity exception is granted. For each condition, cite the specific chart note, prescriber statement, or clinical record that satisfies it. Present this mapping explicitly in the appeal so the reviewer can check each box.